PTIX

Protagenic Therapeutics (PTIX)

About Protagenic Therapeutics (PTIX)

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Details

Daily high

$0.46

Daily low

$0.41

Price at open

$0.43

52 Week High

$1.87

52 Week Low

$0.40

Market cap

3.2M

Dividend yield

0.00%

Volume

172,106

Avg. volume

153,679

P/E ratio

-.35

Protagenic Therapeutics News